Genomic risk-estimation tools for disease and cancer prevention.
| Date | Round | Amount |
|---|---|---|
| Jan 2024 | Funding round Oxford-based Genomics raised £35M led by F-Prime Capital and Foresight Partners for its genomic-prevention tools. | $44M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.